ShareWhy Catalent Stock Dropped Almost 25%Market UpdatesKEY POINTS The healthcare-solutions provider’s first-quarter earnings were below expectations. The company fell short of meeting...Read More Nov 2 0 by Stacy Brooks
ShareWhy Gilead Sciences Stock JumpedMarket UpdatesKEY POINTS Gilead Sciences provided a piece of good news about a cancer treatment. It wasn’t...Read More Aug 16 0 by Stacy Brooks
ShareWhy Pfizer Stock DroppedMarket UpdatesKEY POINTS Several pharmaceutical stocks fell yesterday due to litigation linked to safety concerns with Zantac,...Read More Aug 12 0 by Stacy Brooks
ShareGilead Science is Ready to ReboundMarket UpdatesKEY POINTS Gilead Sciences’ primary market, which focuses on HIV, is in good shape. The firm...Read More Aug 10 0 by Stacy Brooks
ShareWhy Pfizer and BioNTech Are Winning in the Booster MarketMarket UpdatesKEY POINTS Pfizer and BioNTech were given a larger initial order for omicron boosters by the...Read More Aug 4 0 by Stacy Brooks
Share3 Bear Market Stock BuysFeatured NewsWhile 2022 just started, it has been action packed to say the least. We’re out here...Read More Mar 31 0 by Stacy Brooks
Share2 Nasdaq Stocks That Hit Record HighsStock IdeasKEY POINTS: 2 STRONG NASDAQ STOCKS After a strong rally that lasted almost two weeks, the...Read More Mar 23 0 by Stacy Brooks
Share2 Pharma Stocks to Buy NowFeatured NewsKEY POINTS: PHARMA STOCK BUYS Merck and AstraZeneca have strong product portfolios and pipelines. Expect annual...Read More Mar 21 0 by Stacy Brooks
ShareBuy These 3 Cheap Dividend Stocks in MarchFeatured NewsKEY POINTS: CHEAP DIVIDEND STOCKS TO BUY IN MARCH Pfizer could be an even better value...Read More Mar 2 0 by Stacy Brooks